What is included with this book?
Preface | p. xiii |
Introduction to economic analysis in health care | p. 1 |
Life, death, and big business: why health economics is important | p. 1 |
Health care as an economic good | p. 3 |
Health and health care | p. 7 |
Wants, demands and needs | p. 8 |
The production of health and health care | p. 9 |
Deciding who gets what in health care | p. 10 |
Is the market for health care special? | p. 12 |
Describing versus evaluating the use of health care resources | p. 14 |
Judging the use of health care resources | p. 17 |
The demand for health care | p. 21 |
Why study demand? Profits, policy and improving health | p. 21 |
Consumer choice theory | p. 22 |
Preferences and utility | p. 22 |
Budget constraints and maximisation | p. 25 |
Demand functions | p. 27 |
The determinants of demand | p. 28 |
Estimating demand functions | p. 34 |
Price and income elasticity of demand | p. 35 |
Modelling choices about health | p. 37 |
Understanding consumption of health and health care | p. 38 |
Understanding investment in health care | p. 39 |
Predictions of the Grossman model | p. 42 |
Needs, wants and demands | p. 43 |
Asymmetry of information and imperfect agency | p. 44 |
Aggregate demand for health care: theory and evidence | p. 48 |
The production and costs of health care | p. 53 |
Introduction | p. 53 |
The theory of production | p. 54 |
Production functions | p. 54 |
Marginal products | p. 55 |
Technical efficiency and isoquants | p. 56 |
Substitutability between inputs | p. 58 |
Production frontiers | p. 60 |
Multi-product firms | p. 60 |
Returns to scale, additivity and fixed factors | p. 63 |
Costs | p. 67 |
Costs and production | p. 67 |
Cost functions | p. 71 |
Scale economies, long- and short-run cost functions and scope economies | p. 73 |
The supply of health care | p. 79 |
Firms, markets and industries in the health care sector of the economy | p. 79 |
Structure, conduct and performance in the health care industry | p. 81 |
Profit maximisation models | p. 84 |
How firms maximise profits | p. 85 |
Perfect competition | p. 86 |
Monopoly | p. 92 |
Monopolistic competition | p. 94 |
Oligopoly | p. 97 |
Game theory | p. 98 |
Goals other than profit maximisation | p. 101 |
Growth maximisation | p. 102 |
Behavioural theories of the firm | p. 104 |
Utility maximisation | p. 106 |
Maximising net income per physician | p. 108 |
Competition, contestability and industrial policy | p. 109 |
Markets, market failure and the role of government in health care | p. 114 |
Introduction | p. 114 |
Using perfectly competitive markets to allocate resources | p. 114 |
Equilibrium in competitive markets | p. 114 |
The efficiency of competitive markets | p. 115 |
Market failure in health care | p. 117 |
Externalities | p. 117 |
Caring externalities | p. 119 |
Market power | p. 120 |
Public goods | p. 121 |
Information imperfections | p. 123 |
Government intervention in health care | p. 124 |
Direct government involvement in the finance and provision of health care | p. 126 |
Taxes and subsidies | p. 127 |
Regulation | p. 128 |
Provision of information | p. 129 |
The theory of second best | p. 130 |
Government failure | p. 131 |
Health insurance and health care financing | p. 133 |
Uncertainty and health care financing | p. 133 |
Risk and the demand for health insurance | p. 135 |
Risk attitudes and the diminishing marginal utility of income | p. 135 |
The demand for insurance and indifference | p. 137 |
The market for health insurance and market failure | p. 139 |
The supply of health insurance | p. 139 |
Adverse selection | p. 141 |
Moral hazard | p. 145 |
Non-price competition | p. 147 |
Incomplete coverage | p. 147 |
Reimbursement | p. 148 |
Retrospective reimbursement | p. 149 |
Prospective reimbursement | p. 149 |
Integration between third-party payers and health care providers | p. 152 |
Preferred provider organisations | p. 153 |
Health maintenance organisations | p. 153 |
Point-of-service plans | p. 154 |
Health care financing systems | p. 154 |
Equity in health care | p. 163 |
Introduction | p. 163 |
Equity in the finance of health care | p. 165 |
Vertical equity | p. 165 |
Kakwani's progressivity index | p. 166 |
Horizontal equity | p. 169 |
Equity in distribution | p. 170 |
Equity in the distribution of health care, of health or of utility? | p. 170 |
Some concepts of equity | p. 171 |
Measuring equity in distribution | p. 174 |
Horizontal inequity | p. 174 |
Vertical equity | p. 179 |
Inequalities in health | p. 180 |
Health care labour markets | p. 184 |
Labour as a factor of health care production | p. 184 |
Supply of health care labour | p. 186 |
Demand for health care labour | p. 189 |
Wages and employment in perfect labour markets | p. 192 |
Economic rent and transfer earnings | p. 193 |
Wage determination and employment in imperfect labour markets | p. 194 |
Employers and workers with market power | p. 194 |
Labour markets slow to respond to changes in demand and supply | p. 197 |
Non-maximising behaviour | p. 198 |
Discrimination | p. 198 |
Health care labour market shortages | p. 201 |
Welfarist and non-welfarist foundations of economic evaluation | p. 204 |
The normative economics foundations of economic evaluation | p. 204 |
Welfare economics | p. 205 |
The Pareto principle | p. 206 |
Potential Pareto improvements | p. 210 |
Social welfare functions | p. 213 |
Measurability and comparability of utility | p. 218 |
The application of welfare economics | p. 219 |
Non-welfarism | p. 223 |
Is there a link between welfarism and non-welfarism? | p. 229 |
Principles of economic evaluation in health care | p. 232 |
What is economic evaluation? | p. 232 |
The economics foundations of economic evaluation | p. 233 |
Cost-benefit analysis | p. 233 |
Cost-effectiveness analysis | p. 236 |
Economic evaluation applied to health care programmes | p. 238 |
Decision rules for cost-benefit analysis | p. 241 |
Decision rules for cost-effectiveness and cost-utility analysis | p. 242 |
Ratio measures | p. 242 |
The cost-effectiveness plane | p. 243 |
The cost-effectiveness threshold and acceptability | p. 244 |
The incremental cost-effectiveness ratio | p. 245 |
Net benefits | p. 248 |
Probabilistic approaches | p. 249 |
Equity in economic evaluation | p. 250 |
Measuring and valuing health care output | p. 253 |
Introduction | p. 253 |
Monetary valuations of health care benefits | p. 253 |
Revealed preference | p. 254 |
Stated preference | p. 255 |
Discrete choice experiments | p. 259 |
The measurement of health outcomes | p. 261 |
Making health status indicators fit for purpose | p. 262 |
Generic and specific measures | p. 264 |
Profiles and indices | p. 265 |
Measuring health-related quality of life: an indifference curve approach | p. 269 |
The measurement of health gain | p. 270 |
Non-monetary valuation of health states | p. 273 |
Rating scales, category scales and visual analogue scales | p. 274 |
The standard gamble | p. 274 |
Time trade-off | p. 276 |
How do we choose between these methods? | p. 278 |
Multi-attribute utility measures | p. 278 |
The valuation of health states: willingness to pay for health changes | p. 280 |
The value of life | p. 284 |
Economic evaluation methods | p. 286 |
Introduction | p. 286 |
Selecting the viewpoint | p. 286 |
Estimating costs | p. 290 |
Methods and data used in estimating costs | p. 292 |
Which costs should we include? | p. 292 |
Should future costs and cost savings be included? | p. 294 |
What if cost data are from different time periods? | p. 294 |
The measurement of health gain | p. 295 |
Measuring quality-adjusted life year (QALY) gains | p. 295 |
Measuring healthy year equivalents (HYEs) | p. 298 |
Measuring disability-adjusted life years (DALYs) | p. 298 |
Discounting | p. 299 |
The rationale for discounting monetary costs and benefits | p. 299 |
The discounting formula | p. 300 |
The choice of discount rate | p. 301 |
Discounting health effects | p. 303 |
Modelling-based economic evaluation | p. 306 |
Using multiple sources of data | p. 306 |
Decision analysis | p. 308 |
Markov models | p. 311 |
Trial-based economic evaluation | p. 314 |
Dealing with uncertainty: sensitivity analysis | p. 315 |
One-way sensitivity analysis | p. 315 |
Multi-way sensitivity analysis | p. 317 |
Statistically-based sensitivity analysis | p. 318 |
The use of economic evaluation in decision making | p. 321 |
The decision-making context: why is economic evaluation used? | p. 321 |
Who buys economic evaluations? Does it matter? | p. 330 |
Is economic efficiency all that matters? | p. 330 |
Need | p. 331 |
Equity | p. 333 |
Process-of-care considerations | p. 334 |
Ethical imperatives | p. 335 |
How is economic evaluation used to make decisions in practice? | p. 336 |
Cost-effectiveness league tables | p. 336 |
Programme budgeting and marginal analysis | p. 339 |
Programme budgeting | p. 339 |
Marginal analysis | p. 341 |
Cost-effectiveness thresholds | p. 341 |
Evaluating economic evaluation | p. 346 |
References | p. 351 |
Author Index | p. 369 |
Subject Index | p. 373 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.